Top Stock Movers Now: Dexcom, Berkshire Hathaway, Nvidia, and More

Top Stock Movers Now: Dexcom, Berkshire Hathaway, Nvidia, and More

Top Stock Movers Now: Dexcom, Berkshire Hathaway, Nvidia, and More

Key Takeaways

U.S. equities took off at midday after the Labor Department reported job creation in April that was higher than expected. The
Dow Jones Industrial Average
,
S&P 500
, and
Nasdaq
all rose more than 1%.

Dexcom (

DXCM

) was the best-performing stock in the S&P 500 when the maker of glucose monitoring devices for patients with diabetes beat sales estimates on higher demand, and announced a $750 million
stock buyback
program.

Shares of Berkshire Hathaway (

BRK.A

) traded at an all-time high ahead of
Warren Buffett’s
annual meeting in Omaha tomorrow.

Nvidia (

NVDA

) shares gained on a report the
artificial intelligence (AI)
chipmaker is working to design semiconductors to sell in China that would comply with U.S. trade restrictions.

Apple (

AAPL

) shares declined after CEO Tim Cook said Trump administration tariffs could cost the iPhone maker $900 million this quarter.

Shares of Block (

XYZ

) nosedived when the payments technology provider reported worse-than-expected profit, sales, and guidance as it warned it was being more cautious because of macroeconomic uncertainty.

Hologic (

HOLX

) shares tumbled after the medical diagnostic device maker cut its outlook, citing tariffs and geopolitical concerns.

Oil futures slid. Gold prices rose. The yield on the 10-year Treasury note was higher. The U.S. dollar lost ground to the euro, pound, and yen. Most major cryptocurrencies traded higher.

Top Stock Movers Now: Dexcom, Berkshire Hathaway, Nvidia, and More

Read the original article on
Investopedia

Leave a Reply

Your email address will not be published. Required fields are marked *

THIS CONTENT IS CURRENTLY LOCKED.

ApexDator is scheduled to launch in 2026.

Contact the organization’s assistant to receive early access and related benefits in advance, including AI-powered stock picks, signals, and expert-backed research as features roll out.